IEC & IPC Joint Symposium: Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script

Add this event to your calendar

This educational session will explore the clinical challenges of distinguishing between psoriasis and atopic dermatitis in non-classic
presentations, including psoriasiform spongiotic dermatitis and paradoxical drug reactions induced by biologic therapies like anti
TNF or IL-17 inhibitors. Through case studies and evidence-based discussions, participants will learn how to recognize subtle
diagnostic cues and apply the latest treatment strategies, incorporating histopathology and biomarkers into their treatment
decisions. Attendees will gain practical tools to improve diagnostic confidence, optimize patient outcomes, and navigate the
therapeutic complexities of inflammatory skin disease, including mechanistic insights for managing treatment-related rashes.

LEARNING OBJECTIVES

At the conclusion of this symposium, participants will be able to:

1. Analyze the diagnostic challenges of distinguishing psoriasis from atopic dermatitis in non-classic clinical
   presentations, including recognition of psoriasiform spongiotic dermatitis, by identifying at least three
   distinguishing clinical features.
2. Evaluate and apply advanced diagnostic strategies, such as histopathology and biomarker testing, to
   differentiate psoriasis, atopic dermatitis, and paradoxical drug reactions, demonstrating the ability to select at
   least two appropriate tools for challenging adult and pediatric cases.
3. Design and implement evidence-based management plans for paradoxical psoriasiform and eczematous
   eruptions associated with biologic therapies, including TNF-α or IL-17 inhibitors, integrating mechanistic
   insights to optimize skin-related outcomes for patients with psoriasis, atopic dermatitis, or inflammatory bowel
   disease.